Literature DB >> 3463818

Risk factors for estrogen receptor-rich and estrogen receptor-poor breast cancers.

A McTiernan, D B Thomas, L K Johnson, D Roseman.   

Abstract

A population-based case-control study was conducted in King County, WA, to investigate whether risk factors for estrogen receptor (ER)-rich and ER-poor breast cancers differ. Responses to interviews with 329 women with breast cancer who were between 25 and 54 years of age at the time of diagnosis were compared to responses of 332 women of similar age who were selected from female residents of King County by random digit dialing. Of the 329 interviewed cases, 143 had ER-rich tumors, 97 had ER-poor tumors, and 89 had tumors that were not assayed for receptors. The relative risks of ER-rich and ER-poor breast cancers were similar with respect to late menarche, single marital status, history of extended lactation, menopause before age 40, history of benign breast disease, positive family history of breast cancer, obesity, and history of oral contraceptive and noncontraceptive estrogen use. Late age at first full-term pregnancy was a risk factor for ER-rich breast cancer but not for ER-poor breast cancer. This finding suggests that different causal mechanisms operate for these two types of breast cancer and supports the hypothesis that an early first birth protects against breast cancer by reducing the level of ERs in the mammary epithelial cells from which carcinomas develop.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3463818

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  19 in total

1.  Oral contraceptive use and estrogen/progesterone receptor-negative breast cancer among African American women.

Authors:  Lynn Rosenberg; Deborah A Boggs; Lauren A Wise; Lucile L Adams-Campbell; Julie R Palmer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

2.  Breast cancer incidence in young women by estrogen receptor status and race.

Authors:  J L Stanford; R S Greenberg
Journal:  Am J Public Health       Date:  1989-01       Impact factor: 9.308

3.  Association of physical activity with hormone receptor status: the Shanghai Breast Cancer Study.

Authors:  Swann Arp Adams; Charles E Matthews; James R Hebert; Charity G Moore; Joan E Cunningham; Xiou-Oi Shu; Jeanette Fulton; Yutang Gao; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-06       Impact factor: 4.254

4.  A case-control study of oral contraceptive use and incident breast cancer.

Authors:  Lynn Rosenberg; Yuqing Zhang; Patricia F Coogan; Brian L Strom; Julie R Palmer
Journal:  Am J Epidemiol       Date:  2008-12-13       Impact factor: 4.897

5.  Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer.

Authors:  James J Dignam; Kelly Wieand; Karen A Johnson; Bernard Fisher; Lei Xu; Eleftherios P Mamounas
Journal:  J Natl Cancer Inst       Date:  2003-10-01       Impact factor: 13.506

6.  A hospital-based case-control study of breast-cancer risk factors by estrogen and progesterone receptor status.

Authors:  K Y Yoo; K Tajima; S Miura; M Yoshida; H Murai; T Kuroishi; Y Lee; H Risch; R Dubrow
Journal:  Cancer Causes Control       Date:  1993-01       Impact factor: 2.506

7.  Clinical characteristics of breast cancers in African-American women with benign breast disease: a comparison to the surveillance, epidemiology, and end results program.

Authors:  Susanna D Mitro; Rouba Ali-Fehmi; Sudeshna Bandyopadhyay; Baraa Alosh; Bassam Albashiti; Derek C Radisky; Marlene H Frost; Amy C Degnim; Julie J Ruterbusch; Michele L Cote
Journal:  Breast J       Date:  2014-09-08       Impact factor: 2.431

Review 8.  Breastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysis.

Authors:  F Islami; Y Liu; A Jemal; J Zhou; E Weiderpass; G Colditz; P Boffetta; M Weiss
Journal:  Ann Oncol       Date:  2015-10-26       Impact factor: 32.976

Review 9.  What can be learnt from models of incidence rates?

Authors:  Graham A Colditz; Bernard A Rosner
Journal:  Breast Cancer Res       Date:  2006-06-06       Impact factor: 6.466

10.  Risk factors for breast cancer by oestrogen receptor status: a population-based case-control study.

Authors:  J A Cooper; T E Rohan; E L Cant; D J Horsfall; W D Tilley
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.